Sunday, June 26, 2022
No menu items!
HomeBiologyJournal of Parkinson’s Illness welcomes new co-Editor-in-Chief Lorraine V. Kalia, MD, PhD,...

Journal of Parkinson’s Illness welcomes new co-Editor-in-Chief Lorraine V. Kalia, MD, PhD, FRCPC – BIOENGINEER.ORG

[ad_1]

Amsterdam, Might 20, 2022 – The Journal of Parkinson’s Illness (JPD), printed by IOS Press, is happy to announce the appointment of latest co-Editor-in-Chief, Lorraine V. Kalia, MD, PhD, FRCPC. Dr. Kalia joins co-Editor-in-Chief Bas Bloem, MD, PhD, FRCPE, and an eminent worldwide editorial board, who’re devoted to the persevering with success of the world’s main journal in Parkinson’s analysis.

Credit score: Lorraine V. Kalia, MD, PhD, FRCPC

Amsterdam, Might 20, 2022 – The Journal of Parkinson’s Illness (JPD), printed by IOS Press, is happy to announce the appointment of latest co-Editor-in-Chief, Lorraine V. Kalia, MD, PhD, FRCPC. Dr. Kalia joins co-Editor-in-Chief Bas Bloem, MD, PhD, FRCPE, and an eminent worldwide editorial board, who’re devoted to the persevering with success of the world’s main journal in Parkinson’s analysis.

A globally acknowledged authority on Parkinson’s illness, Lorraine V. Kalia, MD, PhD, FRCPC, is an Affiliate Professor and Clinician Scientist within the Division of Neurology on the College of Toronto and a Senior Scientist on the Krembil Analysis Institute of the College Well being Community. She holds appointments with the College of Toronto’s Tanz Centre for Analysis in Neurodegenerative Illnesses and Division of Laboratory Medication and Pathobiology. She can also be a Employees Neurologist within the Morton and Gloria Shulman Motion Problems Clinic and the Edmond J. Safra Program in Parkinson’s Illness on the Toronto Western Hospital, College Well being Community.

Dr. Kalia serves as Co-Chair of the Scientific Points Committee and a Steering Committee Member of the Fundamental Science Particular Curiosity Group of the Worldwide Parkinson and Motion Dysfunction Society. Her scientific work and analysis program give attention to Parkinson’s illness and associated motion issues. With a watch all the time on the clinic, she heads a analysis crew targeted on elucidating the crucial molecular mechanisms chargeable for neurodegeneration in Parkinson’s illness and figuring out therapeutic brokers that may goal these molecular mediators of neurodegeneration.

Dr. Kalia’s appointment follows the departure of certainly one of JPD’s founding editors, Patrik Brundin, MD, PhD, who has moved out of academia and is now Therapeutic Space Chief for Motion Problems at Roche Pharmaceutical Analysis and Early Growth. Dr. Brundin served as co-Editor-in-Chief for 12 years, from its days as a fledging journal to its present place as a number one writer of groundbreaking Parkinson’s analysis. He appears to be like ahead to seeing the journal’s continued development and success.

Dr. Kalia commented, “I’m excited to be getting into the function of co-Editor-in-Chief, though I recognize that Patrik’s sneakers are very giant ones to fill. Bas and Patrik have executed unimaginable work for the journal, growing its attain and affect over the previous few years. I stay up for working with Bas and the crew to take care of this optimistic trajectory by additional creating the journal as a singular open discussion board for wonderful analysis into Parkinson’s that additionally contains the voice of these affected by the illness.”

“I couldn’t be extra thrilled that Lorraine Kalia has consented to affix JPD as the brand new co-Editor-in-Chief,” added Dr. Bloem, Radboud College Nijmegen Medical Centre. “Dr. Kalia has an excellent observe document within the area of Parkinson analysis, and he or she is an excellent colleague to work with. She and I are already engaged on plans to take our journal to the following degree, so please keep tuned for extra data quickly!”

 


[ad_2]

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments